Specialised respiratory
Access educational and practical resources designed to support the severe respiratory multidisciplinary team. It is focused on disease education and is intended for UK healthcare professionals.
Welcome
This specialised respiratory site features a range of educational and practical resources intended for healthcare professionals across the spectrum of severe asthma care, including general practitioners, nurses, pharmacists, and other members of the severe respiratory multidisciplinary team. It is designed to help you to broaden your understanding of the latest evidence on the severe asthma treatment pathway as well as other conditions such as chronic rhinosinusitis with nasal polyps (CRSwNP).
Severe asthma and CRSwNP
The severe asthma and CRSwNP resource site features a range of educational and practical resources intended for healthcare professionals working across the spectrum of severe asthma care, including general practitioners, nurses, pharmacists and other members of the severe asthma multidisciplinary team, and is designed to help you as you broaden your understanding of the latest evidence on the severe asthma treatment pathway and common complications of the condition.
Resources include videos from expert clinicians, summary infographics on remission and CPD accredited resources
Prevalence of severe asthma globally and in the United Kingdom
Oral corticosteroid (OCS) burden
The overuse of OCS continues despite growing evidence in the literature demonstrating the detrimental long-term adverse effects associated with even a short-term, low-dose course of OCS in severe asthma patients.5
There is an urgent need for a system-wide severe asthma guideline to help shift away from inappropriate OCS use and to enable primary and secondary care clinicians to confidently recognise and refer people with suspected severe asthma.
Explore the OCS burden page to view educational material developed following a GSK-led event: "OCS Uncovered" a collaborative and systematic effort with expert clinicians and patients to generate a series of initiatives to protect patients with severe asthma from inappropriate OCS use.
Request a call with the medical team
Request a call with our medical team if you have any questions related to the content of this website. By registering your consent to be contacted, you confirm you are happy for your details, including full name and email address, to be shared with GSK Medical for the purposes of contacting you to respond to specific call request.
Request a call
Meet the team
-
James James
Covers: London and Cambridge
I’m James, the medical & scientific liason (MSL) working across London and the south-east of England. I have generally been involved in the world of respiratory disease over the last 10 years, starting from my research generating novel animal models of respiratory infections at Almirall (Barcelona) as part of my BSc from King’s College London. I then continued my research through a PhD at Imperial College London, where my thesis focused on the mechanisms by which air pollutants can trigger or worsen respiratory symptoms. More recently, I’ve enjoyed applying my research skills and science communication as an MSL within Specialised Respiratory at GSK.
I am based in London, although, I travel any chance I get and have visited over 43 different countries (so far!). On these trips, you will normally find me scuba diving, practising yoga or chasing a pretty sunset.
-
Jess Jess
Covers: West Scotland (Glasgow and Clyde, Lanarkshire, Dumfries and Galloway, Ayrshire and Arran, Forth Valley, Highland), Newcastle, Southampton and Portsmouth
I'm Jess, the MSL for West Scotland and areas of North East and South of England. I have a BSc in Biomedical Sciences from Newcastle University and a PhD in Respiratory Cell Biology from University College London. My career to date has focused on research and development across respiratory diseases, translating basic science into potential new medicines. As an MSL, I am privileged to interact with healthcare professionals who are passionate about understanding clinical data and what this means for their patients, discussing new research ideas and understanding how industry can best support the needs of the NHS.
Outside of work, you can find me travelling between my actual hometown of Newcastle, and adopted home of Glasgow with my husband, Andy. Being by the coast or walking in the hills are our happy places.
-
Julie Julie
Covers: Heartlands, Liverpool, Preston, North + South Wales
I’m Julie, the MSL working across North West England and Wales. I have worked in the pharmaceutical industry for over 25 years and worked in a variety of medical affairs teams for eight years. I have a BSc in Medical Anthropology (Durham University) and an MSc in Applied Research. I am passionate and feel privileged to work in partnership with the medical community; ultimately, bringing scientific solutions to benefit patients with long-term health conditions. As an MSL with GSK specialist respiratory, I enjoy understanding clinical data, and discussing new research interests and how I can support the needs of the National Health Service.
I live on the Wirral, so within easy reach of the North-West Network. Outside of work I am a mum of two teenage boys and enjoy spending time taking long walks with my dog.
Other members of the MSL team cover Yorkshire, Wythenshawe, Nottingham, Leicester, South West of England, Oxford and East Scotland (Lothian, Tayside, Fife, Grampian, Boarders)
Abbreviations
References
- Asthma+Lung UK. Do No Harm report 2023. Available at: https://www.asthmaandlung.org.uk/sites/default/files/2023-03/severe-asthma_report_final.pdf. Accessed March 2025.
- WHO. Global Asthma Report 2022. Available at: http://globalasthmareport.org/resources/Global_Asthma_Report_2022.pdf. Accessed March 2025.
- Reddel HK et al. Eur Respir J. 2022;59:2102730.
- Royal College of Physicians. Why asthma still kills. Available at: https://www.rcplondon.ac.uk/projects/outputs/why-asthma-still-kills. Accessed March 2025.
- Price DB et al. J Allergy Asthma 2018;11:193–204.
April 2025 | NP-GB-ASU-WCNT-250001 (V1.0)